Enhancement of cellular radiation sensitivity through degradation of Chk1 by the XIAP-XAF1 complex

References

• Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004; 73:39-85; PMID:15189136; http://dx.doi.org/10.1146/annurev.biochem.73.011303.073723
   PubMed Web of Science ®Google Scholar
• Zhao H, Watkins JL, Piwnica-Worms H. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc Natl Acad Sci USA 2002; 99(23):14795-800; PMID:12399544; http://dx.doi.org/10.1073/pnas.182557299
   PubMed Web of Science ®Google Scholar
• Sørensen CS, Syljuåsen RG, Falck J, Schroeder T, Rönnstrand L, Khanna KK, Zhou BB, Bartek J, Lukas J. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 2003; 3(3):247-58; PMID:12676583; http://dx.doi.org/10.1016/S1535-6108(03)00048-5
   PubMed Web of Science ®Google Scholar
• Falck J, Mailand N, Syljuåsen RG, Bartek J, Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 2001; 410(6830):842-7; PMID:11298456; http://dx.doi.org/10.1038/35071124
   PubMed Web of Science ®Google Scholar
• Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444(7120):756-60; PMID:17051156; http://dx.doi.org/10.1038/nature05236
   PubMed Web of Science ®Google Scholar
• Raleigh DR, Haas-Kogan DA. Molecular targets and mechanisms of radiosensitization using DNA damage response pathways. Future Oncol 2013; 9(2):219-33; PMID:23414472; http://dx.doi.org/10.2217/fon.12.185
   PubMedGoogle Scholar
• Patil M, Pabla N, Dong Z. Checkpoint kinase 1 in DNA damage response and cell cycle regulation. Cell Mol Life Sci 2013; 70(21):4009-21; PMID:23508805; http://dx.doi.org/10.1007/s00018-013-1307-3
   PubMed Web of Science ®Google Scholar
• Dent P, Tang Y, Yacoub A, Dai Y, Fisher PB, Grant S. CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cycle. Mol Interv 2011; 11(2):133-40; PMID:21540473; http://dx.doi.org/10.1124/mi.11.2.11
   PubMedGoogle Scholar
• Sidi S, Sanda T, Kennedy RD, Hagen AT, Jette CA, Hoffmans R, Pascual J, Imamura S, Kishi S, Amatruda JF, et al. Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. Cell 2008; 133(5):864-77; PMID:18510930; http://dx.doi.org/10.1016/j.cell.2008.03.037
   PubMedGoogle Scholar
• Leung-Pineda V, Huh J, Piwnica-Worms H. DDB1 targets Chk1 to the Cul4 E3 ligase complex in normal cycling cells and in cells experiencing replication stress. Cancer Res 2009; 69(6):2630-7; PMID:19276361; http://dx.doi.org/10.1158/0008-5472.CAN-08-3382
   PubMedGoogle Scholar
• Zhang YW, Brognard J, Coughlin C, You Z, Dolled-Filhart M, Aslanian A, Manning G, Abraham RT, Hunter T. The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress. Mol Cell 2009; 35(4):442-53; PMID:19716789; http://dx.doi.org/10.1016/j.molcel.2009.06.030
   PubMed Web of Science ®Google Scholar
• Zhang YW, Otterness DM, Chiang GG, Xie W, Liu YC, Mercurio F, Abraham RT. Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Mol Cell 2005; 19(5):607-18; PMID:16137618; http://dx.doi.org/10.1016/j.molcel.2005.07.019
   PubMed Web of Science ®Google Scholar
• Salvesen GS, Duckett CS. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 2002; 3(6):401-10; PMID:12042762; http://dx.doi.org/10.1038/nrm830
   PubMed Web of Science ®Google Scholar
• Wilkinson JC, Cepero E, Boise LH, Duckett CS. Upstream regulatory role for XIAP in receptor-mediated apoptosis. Mol Cell Biol 2004; 24(16):7003-14; PMID:15282301; http://dx.doi.org/10.1128/MCB.24.16.7003-7014.2004
   PubMedGoogle Scholar
• Berezovskaya O, Schimmer AD, Glinskii AB, Pinilla C, Hoffman RM, Reed JC, Glinsky GV. Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. Cancer Res 2005; 65(6):2378-86; PMID:15781653; http://dx.doi.org/10.1158/0008-5472.CAN-04-2649
   PubMedGoogle Scholar
• Holcik M, Yeh C, Korneluk RG, Chow T. Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene 2000; 19(36):4174-7; PMID:10962579; http://dx.doi.org/10.1038/sj.onc.1203765
   PubMedGoogle Scholar
• Tong QS, Zheng LD, Wang L, Zeng FQ, Chen FM, Dong JH, Lu GC. Downregulation of XIAP expression induces apoptosis and enhances chemotherapeutic sensitivity in human gastric cancer cells. Cancer Gene Ther 2005; 12(5):509-14; PMID:15706355
   PubMed Web of Science ®Google Scholar
• Sasaki H, Sheng Y, Kotsuji F, Tsang BK. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovariancancer cells. Cancer Res 2000; 60(20):5659-66; PMID:11059757
   PubMed Web of Science ®Google Scholar
• Cao C, Mu Y, Hallahan DE, Lu B. XIAP and surviving as therapeutic targets for radiation sensitization in preclinical models of lung cancer. Oncogene 2004; 23(42):7047-52; PMID:15258565; http://dx.doi.org/10.1038/sj.onc.1207929
   PubMed Web of Science ®Google Scholar
• Galbán S, Duckett CS. XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ 2010; 17(1):54-60; http://dx.doi.org/10.1038/cdd.2009.81
   PubMed Web of Science ®Google Scholar
• Tse MK, Cho CK, Wong WF, Zou B, Hui SK, Wong BC, Sze KH. Domain organization of XAF1 and the identification and characterization of XIAP(RING) -binding domain of XAF1. Protein Sci 2012; 21(10):1418-28; PMID:22811387; http://dx.doi.org/10.1002/pro.2126
   PubMedGoogle Scholar
• Arora V, Cheung HH, Plenchette S, Micali OC, Liston P, Korneluk RG. Degradation of surviving by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex. J Biol Chem 2007; 282(36):26202-9; PMID:17613533; http://dx.doi.org/10.1074/jbc.M700776200
   PubMedGoogle Scholar
• Liston P, Fong WG, Kelly NL, Toji S, Miyazaki T, Conte D, Tamai K, Craig CG, McBurney MW, Korneluk RG. Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. Nat Cell Biol 2001; 3(2):128-33; PMID:11175744; http://dx.doi.org/10.1038/35055027
   PubMedGoogle Scholar
• Galvan V, Kurakin AV, Bredesen DE. Interaction of checkpoint kinase 1 and the X-linked inhibitor of apoptosis during mitosis. FEBS Lett 2004; 558(1-3):57-62; PMID:14759516; http://dx.doi.org/10.1016/S0014-5793(03)01488-1
   PubMedGoogle Scholar
• Wang J, Gu Q, Li M, Zhang W, Yang M, Zou B, Chan S, Qiao L, Jiang B, Tu S. et al. Identification of XAF1 as a novel cell cycle regulator through modulating G(2)/M checkpoint and interaction with checkpoint kinase 1 in gastrointestinal cancer. Carcinogenesis 2009; 30(9):1507-16; PMID:19628579; http://dx.doi.org/10.1093/carcin/bgp155
   PubMedGoogle Scholar
• Kim KS, Choi KJ, Bae S. Interferon-gamma enhances radiation-induced cell death via downregulation of Chk1. Cancer Biol Ther 2012; 13(11):1018-25; PMID:22825336; http://dx.doi.org/10.4161/cbt.20990
   PubMed Web of Science ®Google Scholar
• Holcik M, Gibson H, Korneluk RGXIAP: apoptotic brake and promising therapeutic target. Apoptosis 2001; 6(4):253-61; PMID:11445667; http://dx.doi.org/10.1023/A:1011379307472
   PubMed Web of Science ®Google Scholar
• Dean EJ, Ranson M, Blackhall F, Dive C. X-linked inhibitor of apoptosis protein as a therapeutic target. Expert Opin Ther Targets 2007; 11(11):1459-71; PMID:18028010; http://dx.doi.org/10.1517/14728222.11.11.1459
   PubMed Web of Science ®Google Scholar
• Toledo LI, Murga M, Fernandez-Capetillo O. Targeting ATR and Chk1 kinases for cancer treatment: a new model for new (and old) drugs. Mol Oncol 2011; 5(4):368-73; PMID:21820372; http://dx.doi.org/10.1016/j.molonc.2011.07.002
   PubMedGoogle Scholar
• Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, Bradley A, Donehower LA, Elledge SJ. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev 2000; 14(12):1448-59; PMID:10859164
   PubMed Web of Science ®Google Scholar
• Fong WG, Liston P, Rajcan-Separovic E, St Jean M, Craig C, Korneluk RG. Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics 2000; 70(1):113-22; PMID:11087668; http://dx.doi.org/10.1006/geno.2000.6364
   PubMedGoogle Scholar
• Reinhardt HC, Hasskamp P, Schmedding I, Morandell S, van Vugt MA, Wang X, Linding R, Ong SE, Weaver D, Carr SA, Yaffe MB. DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled byMK2-mediated RNA stabilization. Mol Cell 2010; 40(1):34-49; PMID:20932473; http://dx.doi.org/10.1016/j.molcel.2010.09.018
   PubMed Web of Science ®Google Scholar
• Huh J, Piwnica-Worms H. CRL4(CDT2) targets CHK1 for PCNA-independent destruction. Mol Cell Biol 2013; 33(2):213-26; PMID:23109433; http://dx.doi.org/10.1128/MCB.00847-12
   PubMedGoogle Scholar
• Niida H, Tsuge S, Katsuno Y, Konishi A, Takeda N, Nakanishi M. Depletion of Chk1 leads to premature activation of Cdc2-cyclin B and mitotic catastrophe. J Biol Chem 2005; 280(47):39246-52; PMID:16159883; http://dx.doi.org/10.1074/jbc.M505009200
   PubMed Web of Science ®Google Scholar
• Jurvansuu J, Fragkos M, Ingemarsdotter C, Beard P. Chk1 instability is coupled to mitotic cell death ofp53-deficient cells in response to virus-induced DNA damage signaling. J Mol Biol 2007; 372(2):397-406; PMID:17663993; http://dx.doi.org/10.1016/j.jmb.2007.06.077
   PubMedGoogle Scholar
• Higa LA, Zhang H. Stealing the spotlight: CUL4-DDB1 ubiquitin ligase docks WD40-repeat proteins to destroy. Cell Div 2007; 2:5; PMID:17280619
   PubMed Web of Science ®Google Scholar
• Petroski MD, Deshaies RJ. Function and regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol 2005; 6(1):9-20; PMID:15688063; http://dx.doi.org/10.1038/nrm1547
   PubMed Web of Science ®Google Scholar
• Dohi T, Okada K, Xia F, Wilford CE, Samuel T, Welsh K, Marusawa H, Zou H, Armstrong R, Matsuzawa S, et al. An IAP-IAP complex inhibits apoptosis. J Biol Chem 2004; 279(33):34087-90; PMID:15218035; http://dx.doi.org/10.1074/jbc.C400236200
   PubMedGoogle Scholar
• Pennati M, Folini M, Zaffaroni N. Targeting survivin in cancer therapy: fulfilled promises and open questions. Carcinogenesis 2007; 28(6):1133-9; PMID:17341657; http://dx.doi.org/10.1093/carcin/bgm047
   PubMedGoogle Scholar
• Meuth M. Chk1 suppressed cell death. Cell Div 2010; 5:21; PMID:20813042; http://dx.doi.org/10.1186/1747-1028-5-21
   PubMedGoogle Scholar
• Ohnishi K, Scuric Z, Schiestl RH, Okamoto N, Takahashi A, Ohnishi T. SiRNA targeting NBS1 or XIAP increases radiation sensitivity of human cancer cells independent of TP53 status. Radiat Res 2006; 166(3):454-62; PMID:16972754; http://dx.doi.org/10.1667/RR3606.1
   PubMedGoogle Scholar
• Liang Y, Lin SY, Brunicardi FC, Goss J, Li K. DNA damage response pathways in tumor suppression and cancer treatment. World J Surg 2009; 33(4):661-6; PMID:19034564; http://dx.doi.org/10.1007/s00268-008-9840-1
   PubMedGoogle Scholar
• Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006; 1:2315-9; PMID:17406473; http://dx.doi.org/10.1038/nprot.2006.339
   PubMed Web of Science ®Google Scholar